fda glp-1 compounding enforcement news restricts non-approved compounded weight loss products FDA and Novo Nordisk Warn

While lifestyle and genetics contribute, hormonal shifts are a major factor

Patients starting GLP-1 therapy Patients adjusting doses Patients wanting to reduce side effects or progress Patients who love data or structure The Meds Supported medications Shotsy supports commonly prescribed GLP-1 treatments, including semaglutide and tirzepatide, in both injectable and oral forms, as well as brand-name and compounded options

How to Incorporate Fiber Supplements with GLP-1 Medications Timing and consistency are key when adding fiber supplements to your GLP-1 medication regimen

Tirzepatide is a novel dual GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist recently approved for diabetes and weight loss

Time fluid intake strategically

The authorization was based on the outcome of the SOUL clinical trial